Insulin resistance and cardiometabolic health (IMAGE)
Caption
The TM group showed signicant improvements in HbA1c levels and insulin sensitivity reflected in reductions in HOMA-IR. HbA1c is considered a surrogate endpoint for diabetes. IR is a central feature of metabolic syndrome and type II diabetes. It is well-established contributor to hyperglycemia, endothelial dysfunction, arterial stiffness, and systemic inflammation, all of which accelerate the development of diabetes and atherosclerotic CVD. The observed improvements suggest that TM may benecially modulate metabolic and neuroendocrine mechanisms associated with chronic stress and cardiometabolic disease. These findings align with prior research reporting reductions in IR and cardiometabolic risk with TM practice in a racially diverse population.
Credit
Maharishi International University
Usage Restrictions
None
License
Original content